This blog explores the science behind GLP-1 plateaus , why they occur, and what providers can do to prevent, reverse, or bypass them through smart cycling strategies, metabolic support, and adjunctive protocols like SLM+
Figure 1: Measured changes in HbA1c, body weight, and fasting plasma glucose in response to varying doses of semaglutide, an active control, or a placebo 2) The research team of Davies et
It is an injectable drug that combines the effects of two natural hormones, GLP-1 and GIP, which work together to regulate appetite and improve metabolism
Safety and tolerability of RYBELSUS were evaluated across 10 different clinical trials 1-4,a Safety and tolerability of RYBELSUS were evaluated across 10 different clinical trials 1-4,a The most frequently reported adverse reactions were GI disorders, including nausea, abdominal pain, and diarrhea Nausea, vomiting, and/or diarrhea occurred mostly during dose escalation 4% and 8% of patients discontinued RYBELSUS 7 mg and 14 mg, respectively, due to GI adverse reactions, compared to 1% of patients receiving placebo GI=gastrointestinal
Semaglutide is not a magic injection
Selenium may play a role in the pathogenesis of PCOS related with hyperandrogenism